期刊文献+

mTOR和PTEN在非小细胞肺癌组织中的表达及临床意义 被引量:9

Expression and Clinical Significance of mTOR and PTEN in Non-small Cell Lung Cancer
下载PDF
导出
摘要 背景与目的mTOR是调节细胞生长和增殖的重要信号转导分子,也是一种蛋白激酶。它通过活化下游的相关的效应蛋白发挥作用。在信号转导通路中PTEN基因可通过对该信号途径的负调控而抑制mTOR的活化。本研究通过分析mTOR信号转导途径中mTOR和PTEN基因在非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中的表达和临床意义。方法外科手术中获取65例NSCLC组织及30例癌旁组织,RT-PCR技术检测NSCLC组织及癌旁组织中mTOR和PTEN基因的表达水平。结果mTOR在NSCLC组织中表达量(0.23±0.16)显著高于癌旁组(0.12±0.09)(P<0.01),PTEN在NSCLC组织中表达量(0.19±0.28)显著低于癌旁组(0.53±0.28)(P<0.01)。mTOR和PTEN与病人的性别、年龄、病理类型、淋巴结转移情况无关,与病人的肿瘤大小有关。结论mTOR在NSCLC中被激活,PTEN在NSCLC组织表达缺失或减少,mTOR通路的激活和PTEN表达缺失在NSCLC发生发展中起到一定的作用。 Background and objective It has been proved that mTOR was an important signal transduction molecular and protein kinase regulating cell growth and proliferation, and mTOR could activate the downstream protein effector. PTEN could negatively regulate mTOR signal pathway and inhibit its activity. The aim of this study is to detect the mRNA expression levels of mTOR and PTEN gene, which are the key genes of mTOR signaling pathway in human non-small cell lung cancer (NSCLC) tissue. The relationship between mTOR signaling pathway and NSCLC is also explored. Methods Lung cancer tissue specimens were obtained from 65 patients. Adjacent-tumor non-small cell lung cancer tissues from the 30 patients were served as control. The RT-PCR technique was used to detect the mTOR and PTEN gene expression levels. Results The average mRNA expression levels of mTOR gene were significantly higher (0.23±0.16) in lung cancer than in adjacent-tumor tissue (0.12±0.09)(P0.01). The average mRNA expression levels of PTEN gene were (0.19±0.28) in lung cancer, while the mRNA expression levels of PTEN gene were (0.53±0.28) in adjacent-tumor tissue (P0.01). The levels of PTEN gene expression in non-small cell lung cancer were significantly lower than that in adjacent-tumor lung tissue. There are not significant relationship between mTOR and PTEN gene expression levels and patients’ age, gender, pathological type, differentiation, lymph node metastasis, except tumor size. Conclusion The expression of mTOR is activated in NSCLC. The expression of PTEN is absent or decreased. The mTOR activated in NSCLC may be correlate with the absent or decreased of PTEN. The absent or decreased expression of PTEN and the actived mTOR may play important roles in carcinogenesis and metastasis of NSCLC.
出处 《中国肺癌杂志》 CAS 2010年第7期717-721,共5页 Chinese Journal of Lung Cancer
基金 北京市科技新星基金(No.2006B34) 北京市优秀人才培养基金(No.20061D03)资助~~
关键词 MTOR PTEN 逆转录聚合酶链反应 肺肿瘤 mTOR protein PTEN protein Reverse transcriptase polymerase chain reaction Lung neoplasms
  • 相关文献

参考文献12

  • 1冯美江,丁新生.Akt与细胞生存[J].国外医学(分子生物学分册),2002,24(5):283-285. 被引量:23
  • 2Pisick E, Jagadeesh S, Salgia R. Receptor tyrosine kinases and inhibitors in lung cancer. Sci World J, 2004, 6(4): 589-604.
  • 3LiJ, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brainp breast and prostate cancer. Science, 1997, 275(5308): 1943-1947.
  • 4Steelman LS, B ertrrand FE, McCubrey JA. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention. Expert Opin Ther Targets, 2004, 8(6): 537-550.
  • 5Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Can, 2006. 6(9): 729-734.
  • 6Shaw RJ, Canfley LC. Ras, PI(3)K and roTOR signalling controls turnout cell growth. Nature, 2006, 441 (7092): 424-430.
  • 7Massion PP, Taflan PM, Shyr Y, et al. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med, 2004, 170(10): 1088-1094.
  • 8Conde E, Angulo B, Tang M, et al. Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling. Clin Cancer Res, 2006, 12(3): 710-717.
  • 9Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 1997, 275 (5300): 628-630.
  • 10Tamura M, Gu I, Takino T, et al. Tumor suppressor PTEN inhibition of cell invision, migration, and growth: differential involvement of focal adhesion kinase and p 130cas. Cancer Res, 1999, 59(2): 442-449.

二级参考文献19

  • 1[1]VauxDL, Korsmeyer SJ. Cell, 1999, 96:245
  • 2[2]Downward J. Nature, 1994; 371:378
  • 3[3]Siren AL et al. Proc Natl Acad Sci USA, 2001; 98(7): 4044
  • 4[4]Aoki M et al. Proc Natl Acad Sci USA, 1998; 95:14950
  • 5[5]Cantley LC, Neel BG. Proc Natl Acad Sci USA,1999;96:4240
  • 6[6]Skorski T et al. EMBO J,1997;16:6151
  • 7[7]Bellacosa A et al. Int J Cancer, 1995;64:280
  • 8[8]Dudek H et al. Science,1997;275:661
  • 9[9]Zundel W, Giaccia A. Genes Dev,1998;12:1941
  • 10[10]Widmann C et al. J Biol Chem, 1998; 273:7141

共引文献22

同被引文献127

  • 1才保加,祁玉娟,周为,王晓龙.结肠腺癌患者癌组织中TPX2、PTEN和Ki67的关系及临床意义[J].中国老年学杂志,2014,34(9):2399-2401. 被引量:5
  • 2Liu JF, Zhou XK, Chen JH, Yi G, Chen HG, Ba MC, Lin SQ, Qi YC..Up-regulation of PIK3CA promotes metastasis in gastric carcinoma[J].World Journal of Gastroenterology,2010,16(39):4986-4991. 被引量:20
  • 3卢美松,邓锁,肖兰,梁铭霖,王泽华.卵巢癌耐药细胞株的P38 MAPK活性与凋亡关系的研究[J].哈尔滨医科大学学报,2007,41(2):125-128. 被引量:5
  • 4Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 5Lorusso PM. Mammalian target of rapamycin as a rational thera- peutic target for breast cancer treatment[J]. Oncology, 2013,84 (1) :43-56.
  • 6McAuliffe PF, Meric-Bernstam F, Mills GB, et al. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis[J]. Clin Breast Cancer,2010,10(Suppl 3) :59-65.
  • 7Kim EK,Kim HA,Koh JS,et al. Phosphorylated S6K1 is a possi- ble marker for endocrine therapy resistance in hormone receptor- positive breast cancer[J]. Breast Cancer Res Treat, 2011, 126 (1):93-99.
  • 8Remmele W, Stegner HE. Recommendation for uniform defini- tion of an immunoreactivc score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue [in German]. Pathologe, 1987,8(3) : 138-140.
  • 9Sato T, Nakashima A, Guo L, et al. Single amino-acid changes that confer constitutive activation of roTOR are discovered in hu- man cancer[J]. Oncogene, 2010,29 (16) : 2746-2752.
  • 10Montero JC,Chen X, Ocana A, et al. Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells : therapeutic implications[J]. Mol Cancer Ther, 2012,11 (6) 1342-1352.

引证文献9

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部